MAXZIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Hydrochlorothiazide; Triamterene.
| Product ID | 0378-0460_0e54ebec-df86-4205-9434-315913b56a94 |
| NDC | 0378-0460 |
| Product Type | Human Prescription Drug |
| Proprietary Name | MAXZIDE |
| Generic Name | Maxzide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1988-05-13 |
| Marketing End Date | 2024-04-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019129 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| Pharm Classes | Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 1988-05-13 |
| Marketing End Date | 2024-04-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019129 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1988-05-13 |
| Marketing Category | NDA |
| Application Number | NDA019129 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1988-05-13 |
| Marketing End Date | 2015-09-22 |
| Ingredient | Strength |
|---|---|
| TRIAMTERENE | 75 mg/1 |
| SPL SET ID: | e92eda49-861e-4c79-b446-ec1213151d92 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-0460 | MAXZIDE | maxzide |
| 0378-0464 | MAXZIDE-25 | maxzide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() MAXZIDE 73483161 1376817 Live/Registered |
AMERICAN CYANAMID COMPANY 1984-06-01 |
![]() MAXZIDE 73449182 1429786 Live/Registered |
American Cyanamid Company 1983-10-24 |